Blog - Page 3458 of 5493

ThursdayNov 04, 2010 2:37 pm

STWA, Inc. (ZERO.OB) Engages Colfax to Generate Prototype for Full Scale Testing of Breakthrough Oil Pipeline Energy-Efficiency Technology

STWA, www.stwa.com – masters of pioneering energy efficiency solutions for large-scale energy production and diesel fleets, today reported engagement of the renowned global provider of critical fluid-handling systems Colfax Corporation for the production of a full-scale prototype of ZERO’s revolutionary AOT™ (applied oil technology). The US DOE’s Rocky Mountain Oilfield Testing Center (RMOTC) will play host to full scale testing of ZERO’s AOT technology, utilizing the prototype and ultimately offering a clearer picture of the huge benefit this technology represents to the industry as a whole. The reduction of costs associated with transporting crude oil through pipelines, promised by this…

ThursdayNov 04, 2010 11:32 am

PetroQuest Energy (PQ) Reports Results of Third Quarter Oil And Gas Operations

PetroQuest Energy released an operational update for the third quarter of 2010, including new disclosures on its exploration and development activities in various onshore and offshore oil and gas areas of the United States. PetroQuest Energy reported a slight decline in total oil and gas production during the quarter. The company had total production of 7.9 billion cubic feet equivalents in the quarter ending 9/30/2010, compared to 8.0 billion cubic feet equivalents in the same quarter of 2009. PetroQuest Energy said that the company has recompleted a well located in the Ship Shoal 72 field in the Gulf of Mexico.…

ThursdayNov 04, 2010 11:30 am

Penn Virginia Corp. (PVA) Issues Operations Update

Penn Virginia Corp. issued an operations update on the company’s oil and gas activities in various domestic basins during the third quarter of 2010. The company is active in many different areas, including the Granite Wash, Selma Chalk and Cotton Valley plays. Penn Virginia Corp. reported total production of 13.3 billion cubic feet of natural gas equivalent during the third quarter of 2010. This comes to an average of 144.3 million cubic feet of natural gas equivalent per day. In the same quarter of 2009, Penn Virginia Corp. reported total production of 11.2 billion cubic feet of natural gas equivalent,…

ThursdayNov 04, 2010 10:44 am

Integrated Environmental Technologies Ltd. (IEVM.OB) Video Chart for Thursday, November 4, 2010

IEVM is significantly off its 52-week highs and sitting on an area that has proven to hold as good support in the past. The volume is low, but we still have it on watch for an increase in volume and a possible move north. Please click the following link: http://www.qualitystocks.net/videocharts.php Let us hear your thoughts below:

ThursdayNov 04, 2010 10:13 am

Uranium Energy Corp. (UEC) Jumps As Uranium Prices Come Back

The price of uranium, like that of all commodities, is based on a volatile mix of many variables feeding supply and demand. Like rogue waves on a choppy sea, spikes and troughs can easily mislead, disguising powerful general trends. When the spot price of uranium peaked in 2007, only to fall back over the following few years, there was no shortage of pundits attempting to target the bottom, which now appears to have been hit and solidly defined. The spot price of uranium has now increased 25% since earlier this year, and exploration/development companies like Uranium Energy Corp. have shot…

ThursdayNov 04, 2010 8:14 am

LianDi Clean Technology Inc. (LNDT.OB) Announces Major Contract with Sinopec Mitsubishi Chemical

Located in Beijing, China, LianDi serves the largest Chinese petroleum and petrochemical companies by providing clean technology, downstream flow equipment and engineering services. While only established in 2004, LianDi is quickly becoming a major player in the rapidly growing clean technology market for oil refineries in China. Today, LianDi announced four contracts from Sinopec Mitsubishi Chemical with a combined worth of $3 million. With these contracts, the young company will supply 222 valves to Sinopec Mitsubishi, a subsidiary of Sinopec. LianDi expects delivery to Sinopec Mitsubishi Chemical in the first half of 2011. LianDi Clean Technology will supply all the…

ThursdayNov 04, 2010 8:10 am

Echo Therapeutics Inc. (ECTE.OB) Receives Qualifying Therapeutic Discovery Project Grant for 2009 Research and Development Endeavors

Echo Therapeutics, Inc. announced this morning that it received a Qualifying Therapeutic Discovery Project (QTDP) grant from the U.S. government in the amount of $244,479 related to its 2009 research and development expenditures. Based on its actual and projected R&D spending for 2010, Echo expects to receive an additional grant of up to approximately $244,000 after submission of its 2010 tax returns. The U.S. Department of Health and Human Services issues QTDP grants to support innovative projects that have reasonable potential to result in new therapies, reduce health care costs or significantly advance the goal of curing cancer. Created under…

ThursdayNov 04, 2010 8:07 am

Dionics, Inc. (DION.OB) Announces Progress in Initiative Aimed at Expanding Asian Market

Yesterday, Dionics, Inc. announced the progress they have made in regards to generating growth in the expanding Chinese market. Dionics, a manufacturer of semiconductors and microelectronics, is known particularly for its photovoltaic MOSFET drivers. Among the steps taken are the hiring of a respected local Chinese consulting firm, and having an operating sales and marketing function in Bejing through this consulting firm. In addition, these consultants are in the process of screening candidates for Merger/Acquisition routes. Further action is being taken in ongoing negotiations with a large number of Chinese electronics companies to distribute their MOSFET drivers in the Chinese…

ThursdayNov 04, 2010 8:04 am

InSite Vision Inc. (INSV.OB) Awarded Therapeutic Discovery Project Grant

InSite Vision Inc. announced yesterday that they will receive $489,000 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program. The grant was awarded in recognition of two clinical-stage programs. One is ISV-502, a product candidate being developed for the treatment of blepharitis. The other is ISV-303; a topical anti-inflammatory product intended to reduce the pain and inflammation associated with ocular surgery. The QTDP credit is available to biotechnology companies who are conducting studies or carrying out research for the purpose of securing approval from the U.S. Food and Drug Administration for products that address an area of unmet medical…

ThursdayNov 04, 2010 8:02 am

Access Pharmaceuticals, Inc. (ACCP.OB) Commences Phase II Trial for Ovarian Drug

Access Pharmaceuticals Inc. is a biopharmaceutical company that develops and commercializes proprietary products for the treatment and supportive care of cancer patients. The company recently commenced a phase II combination trial for its second generation DACH-platinum ovarian cancer drug ProLindac. The trial is a study of intravenously administered ProLindac, in combination with paclitaxel; the trial will be conducted in up to eight European centers. Proessor Esteban Cvitkovic, vice chairman, Europe, and senior director of Clinical Oncology R&D for Access, said the phase II trial is one of many studies to observe potential applications for ProLindac in the healthcare market. "We…

Site Search

Company Search